15:43:33
英国 United Kingdom
富时100指数周三小幅下跌,在连续16个交易日上涨后暂停。制药巨头阿斯利康(AstraZeneca)和葛兰素史克(GSK)的大幅下跌打压了投资者情绪,这两家公司分别下跌了近2.5%和4%以上,此前美国市场对维奈·普拉萨德(Vinay Prasad)的任命产生了负面反应。尽管一些支持性的企业更新,但整体市场情绪喜忧参半。BAE系统公司在全球国防需求强劲的情况下重申了其前景,Trainline的利润超出了预期。在政策方面,英国和美国官员正在进行密集会谈,旨在达成一项新的经济协议以降低关税,这增加了减少贸易摩擦的希望。这些讨论是在英国最近与印度达成贸易协议之后进行的,这是英国脱欧以来最大的贸易协议。与此同时,随着美中贸易谈判在瑞士恢复,全球市场仍持谨慎态度,此举旨在缓和一直使全球经济前景紧张的紧张局势。
The FTSE 100 edged lower on Wednesday, pausing after 16 consecutive sessions of gains. Investor sentiment was weighed down by sharp losses in pharmaceutical giants AstraZeneca and GSK, which dropped nearly 2.5% and over 4%, respectively, following negative reaction in US markets to the appointment of Vinay Prasad. The broader market mood was mixed despite some supportive corporate updates. BAE Systems reaffirmed its outlook amid strong global defense demand, and Trainline exceeded profit expectations. On the policy front, UK and US officials are in intensive talks aimed at reaching a new economic deal to ease tariffs, raising hopes of reduced trade frictions. These discussions follow the UK’s recent trade agreement with India, its biggest since Brexit. Meanwhile, global markets remain cautious as US-China trade negotiations resume in Switzerland, a move aimed at cooling tensions that have been straining the global economic outlook.